Abstract
BACKGROUND: Persons with persistent mental illness are at risk for failure to receive medical services. In order to deliver appropriate preventive and primary care for this population, it is important to determine which chronic medical conditions are most common.
OBJECTIVE: We examined chronic medical comorbidity in persons with schizophrenia using validated methodologies.
DESIGN: Retrospective analysis of longitudinal administrative claims data from Wellmark Blue Cross/Blue Shield of Iowa.
PARTICIPANTS: Subjects with schizophrenia or schizoaffective disorder (N=1,074), and controls (N=726,262) who filed at least 1 claim for medical services, 1996 to 2001.
MEASUREMENTS: Case subjects had schizophrenia as the most clinically predominant psychotic disorder, based on psychiatric hospitalization, psychiatrist diagnoses, and outpatient care. Controls had no claims for any psychiatric comorbidity. Using a modified version of the Elixhauser Comorbidity Index, inpatient and outpatient claims were used to determine the prevalence of 46 common medical conditions. Odds ratios (ORs) were adjusted for age, gender, residence, and nonmental health care utilization using logistic regression.
RESULTS: Subjects with schizophrenia were significantly more likely to have 1 or more chronic conditions compared with controls. Adjusted OR (95% confidence interval [CI]) were 2.62 (2.09 to 3.28) for hypothyrodisim, 1.88 (1.51 to 2.32) for chronic obstructive pulmonary disease, 2.11 (1.36 to 3.28) for diabetes with complications, 7.54 (3.55 to 15.99) for hepatitis C, 4.21 (3.25 to 5.44) for fluid/electrolyte disorders, and 2.77 (2.23 to 3.44) for nicotine abuse/dependence.
CONCLUSIONS: Schizophrenia is associated with substantial chronic medical burden. Familiarity with conditions affecting persons with schizophrenia may assist programs aimed at providing medical care for the mentally ill.
Similar content being viewed by others
References
Subramaniam M, Chong SA, Pek E. Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia. Can J Psychiatry. 2003;48:345–7.
Ryan MC, Thakore JH. Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci. 2002;71:239–57.
Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry. 2003;160:284–9.
Adler LE, Griffith JM. Concurrent medical illness in the schizophrenic patient. Epidemiology, diagnosis, and management. Schizophr Res. 1991;4:91–107.
Dembling B, Chen D, Vachon L. Life expectancy and causes of death in a population treated for serious mental illness. Psychiatr Serv. 1999;50:1036–42.
Druss BG, Bradford WD, Rosenheck RA, Radford MJ, Krumholz HM. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry. 2001;58:565–72.
Folsom DP, McCahill M, Bartels SJ, Lindamer LA, Ganiats TG, Jeste DV. Medical comorbidity and receipt of medical care by older homeless people with schizophrenia or depression. Psychiatr Serv. 2002;53:1456–60.
Giel R, Dijk S, van Weerden-Dijkstra JR. Mortality in the long-stay population of all Dutch mental hospitals. Acta Psychiatr Scand. 1978;57:361–8.
Makikyro T, Karvonen JT, Hakko H, et al. Comorbidity of hospital-treated psychiatric and physical disorders with special reference to schizophrenia: a 28 year follow-up of the 1966 northern Finland general population birth cohort. Public Health. 1998;112:221–8.
Dickerson FB, McNary SW, Brown CH, Kreyenbuhl J, Goldberg RW, Dixon LB. Somatic healthcare utilization among adults with serious mental illness who are receiving community psychiatric services. Med Care. 2003;41:560–70.
Sokal J, Messias E, Dickerson FB, et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis. 2004;192:421–7.
Dixon L, Postrado L, Delahanty J, Fischer PJ, Lehman A. The association of medical comorbidity in schizophrenia with poor physical and mental health. J Nerv Ment Dis. 1999;187:496–502.
Metropolitan and Micropolitan Statistical Areas: U.S. Census Bureau 2006. Available at: http://www.census.gov/population/www/estimates/metroarea.html. Accessed February 2, 2006.
Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.
Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258–67.
SAS. SAS Version 8.2. Cary, NC: SAS System.
Hall RC, Gardner ER, Popkin MK, Lecann AF, Stickney SK. Unrecognized physical illness prompting psychiatric admission: a prospective study. Am J Psychiatry. 1981;138:629–35.
Koranyi EK. Morbidity and rate of undiagnosed physical illnesses in a psychiatric clinic population. Arch Gen Psychiatry. 1979;36:414–9.
Koran LM, Sox HC Jr, Marton KI, et al. Medical evaluation of psychiatric patients. I. Results in a state mental health system. Arch Gen Psychiatry. 1989;46:733–40.
Lyketsos CG, Dunn G, Kaminsky MJ, Breakey WR. Medical comorbidity in psychiatric inpatients: relation to clinical outcomes and hospital length of stay. Psychosomatics. 2002;43:24–30.
Roca RP, Breakey WR, Fischer PJ. Medical care of chronic psychiatric outpatients. Hosp Community Psychiatry. 1987;38:741–5.
Druss BG, Rosenheck RA. Mental disorders and access to medical care in the United States. Am J Psychiatry. 1998;155:1775–7.
Levinson Miller C, Druss BG, Dombrowski EA, Rosenheck RA. Barriers to primary medical care among patients at a community mental health center. Psychiatr Serv. 2003;54:1158–60.
Lambert TJ, Velakoulis D, Pantelis C. Medical comorbidity in schizophrenia. Med J Aust. 2003;178(suppl):S67–70.
Dixon L. Papers on medical conditions of persons with severe mental illness. Psychiatr Serv. 2002;53:863.
Dickey B, Normand SL, Weiss RD, Drake RE, Azeni H. Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv. 2002;53:861–7.
Druss BG. The mental health/primary care interface in the United States: history, structure, and context [see comment]. Gen Hosp Psychiat. 2002;24:197–202.
Samet JH, Larson MJ, Horton NJ, Doyle K, Winter M, Saitz R. Linking alcohol- and drug-dependent adults to primary medical care: a randomized controlled trial of a multi-disciplinary health intervention in a detoxification unit. Addiction. 2003;98:509–16.
Druss BG, Rohrbaugh RM, Levinson CM, Rosenheck RA. Integrated medical care for patients with serious psychiatric illness: a randomized trial. Arch Gen Psychiatry. 2001;58:861–8.
Kishi Y, Kathol RG. Integrating medical and psychiatric treatment in an inpatient medical setting. The type IV program. Psychosomatics. 1999;40:345–55.
Golomb BA, Pyne JM, Wright B, Jaworski B, Lohr JB, Bozzette SA. The role of psychiatrists in primary care of patients with severe mental illness. Psychiatr Serv. 2000;51:766–73.
Author information
Authors and Affiliations
Corresponding author
Additional information
This research was supported by NIMH K08 MH01932-01A1 “Epidemiology of Cancer and Mental Illness in Rural Areas” (Dr. Carney). The authors thank Dr. Sheila Riggs of Wellmark Blue Cross Blue Shield of Iowa and South Dakota for granting access to the data used in this research.
Rights and permissions
About this article
Cite this article
Carney, C.P., Jones, L. & Woolson, R.F. Medical comorbidity in women and men with schizophrenia. J Gen Intern Med 21, 1133–1137 (2006). https://doi.org/10.1111/j.1525-1497.2006.00563.x
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1525-1497.2006.00563.x